3-(3,5-dihydroxyphenyl)-1-propanoic acid

structure in first source

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Ischemic Stroke 01/01/2019 - "The aim of this study was to examine whether plasma 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), a biomarker of whole-grain wheat and rye intake, is associated with risk of ischemic stroke. "
2.	Non-alcoholic Fatty Liver Disease 01/01/2022 - "To examine whether plasma 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), a biomarker of whole-grain wheat and rye intake, is associated with nonalcoholic fatty liver disease (NAFLD). " 01/01/2022 - "To examine whether plasma 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), a biomarker of whole-grain wheat and rye intake, is associated with nonalcoholic fatty liver disease (NAFLD). "
3.	Type 2 Diabetes Mellitus (MODY) 01/01/2018 - "To examine the association of plasma alkylresorcinol metabolite 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), a biomarker of whole-grain wheat and rye intake, with type 2 diabetes (T2D) and impaired glucose regulation (IGR) in a Chinese population. "

1.	Biomarkers (Surrogate Marker)
2.	3,4-dihydroxyphenylpyruvic acid
3.	Glucose (Dextrose)